Clinical Trials Directory

Trials / Completed

CompletedNCT01253889

Sweetheart Study: Oral Glucose for Reducing Stress During Echocardiographic Assessment in Infants in the NICU

Glucose 25% and Facilitated Tucking for Reducing Procedural Stress During Neonatologist-performed Cardiac Echocardiography in Infants in the NICU

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Children's & Women's Health Centre of British Columbia · Academic / Other
Sex
All
Age
6 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effect of a 25% glucose solution given via a soother with or without facilitated tucking with a similarly administered water placebo (control condition) on infant stress responses during and immediately after a neonatologist performed ECHO (np-ECHO).

Detailed description

One hundred and four infants were randomized to one of four groups during a single np-ECHO examination, at the discretion of the medical team. Randomization to soother and water (Control) with and without facilitated tucking or to soother and 25% glucose (Intervention) with or without facilitated tucking will be determined by generating randomly permuted sequential blocks of four and six allocation numbers.

Conditions

Interventions

TypeNameDescription
DRUGGlucose 25% oral solution0.5ml of 25% glucose (26-31 weeks gestational age group) or 1.0 ml of 25% glucose (32-42 weeks gestational age group). This application can be repeated if necessary to a maximum of four times, adding up to max 2ml of 25% glucose in the 26-31 weeks gestational age group or 4ml of 25% glucose in the 32-42 weeks gestational age group.
OTHEROral water0.5ml of oral water (26-31 weeks gestational age group) or 1.0 ml of oral water (32-42 weeks gestational age group). This application can be repeated if necessary to a maximum of four times, adding up to max 2ml of oral water in the 26-31 weeks gestational age group or 4ml of oral water in the 32-42 weeks gestational age group.

Timeline

Start date
2010-12-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2010-12-06
Last updated
2017-02-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01253889. Inclusion in this directory is not an endorsement.